Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEK Athena Technology Acquisition	$10.00	$9.73	$1.00 ▼ $13.41	$101.50M	0.37	4,013 shs	N/A
CRTX Cortexyme	$1.69 +0.6%	$1.60	$1.78 ▼ $40.66	$50.96M	1.4	620,672 shs	166,060 shs
HSTM HealthStream	$26.68 +0.7%	$26.95	$25.36 ▼ $34.24	$790.80M	0.43	179,504 shs	217,296 shs
OMCL Omnicell	$31.61 -0.3%	$29.45	$22.66 ▼ $55.74	$1.45B	0.78	568,872 shs	485,100 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEK Athena Technology Acquisition	0.00%	0.00%	0.00%	0.00%	-11.89%
CRTX Cortexyme	0.00%	+2.42%	-7.65%	+98.82%	+208.00%
HSTM HealthStream	0.00%	+1.96%	+0.80%	-9.06%	-4.95%
OMCL Omnicell	0.00%	+2.79%	+17.89%	+13.79%	-25.52%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATEK Athena Technology Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRTX Cortexyme	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HSTM HealthStream	4.5226 of 5 stars	2.4	3.0	1.7	4.8	2.9	3.3	1.3
OMCL Omnicell	2.9746 of 5 stars	3.3	3.0	0.0	0.0	2.6	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATEK Athena Technology Acquisition	0.00	N/A	N/A	N/A
CRTX Cortexyme	0.00	N/A	N/A	N/A
HSTM HealthStream	2.80	Moderate Buy	$31.00	16.19% Upside
OMCL Omnicell	2.57	Moderate Buy	$46.71	47.78% Upside

Current Analyst Ratings Breakdown

Latest ATEK, CRTX, OMCL, and HSTM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	OMCL Omnicell	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$57.00 ➝ $55.00
8/7/2025	HSTM HealthStream	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$29.00 ➝ $28.00
7/21/2025	OMCL Omnicell	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$37.00 ➝ $40.00
5/23/2025	OMCL Omnicell	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
5/23/2025	OMCL Omnicell	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$30.00 ➝ $34.00
5/23/2025	OMCL Omnicell	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$35.00 ➝ $37.00

(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATEK Athena Technology Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
CRTX Cortexyme	N/A	N/A	N/A	N/A	$3.97 per share	N/A
HSTM HealthStream	$291.65M	2.71	$2.44 per share	10.93	$11.81 per share	2.26
OMCL Omnicell	$1.15B	1.26	$3.05 per share	10.35	$26.84 per share	1.18

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATEK Athena Technology Acquisition	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
CRTX Cortexyme	-$89.94M	-$2.97	N/A	N/A	N/A	N/A	-70.96%	-63.53%	N/A
HSTM HealthStream	$20.01M	$0.67	39.82	41.69	3.32	6.89%	5.70%	3.99%	10/20/2025 (Estimated)
OMCL Omnicell	$12.53M	$0.50	63.22	25.49	9.25	2.01%	4.27%	2.44%	10/29/2025 (Estimated)

Latest ATEK, CRTX, OMCL, and HSTM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/4/2025	Q2 2025	HSTM HealthStream	$0.16	$0.18	+$0.02	$0.18	$74.39 million	$74.40 million
7/31/2025	Q2 2025	OMCL Omnicell	$0.30	$0.45	+$0.15	$0.12	$275.57 million	$290.56 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATEK Athena Technology Acquisition	N/A	N/A	N/A	N/A	N/A
CRTX Cortexyme	N/A	N/A	N/A	N/A	N/A
HSTM HealthStream	$0.12	0.45%	N/A	17.91%	2 Years
OMCL Omnicell	N/A	N/A	N/A	N/A	N/A

Latest ATEK, CRTX, OMCL, and HSTM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2025	HSTM HealthStream	quarterly	$0.0310	0.5%	8/18/2025	8/18/2025	8/29/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATEK Athena Technology Acquisition	N/A	N/A	N/A
CRTX Cortexyme	N/A	9.92	9.92
HSTM HealthStream	N/A	1.25	1.25
OMCL Omnicell	0.13	1.42	1.24

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATEK Athena Technology Acquisition	17.30%
CRTX Cortexyme	63.18%
HSTM HealthStream	69.58%
OMCL Omnicell	97.70%

Insider Ownership

Company	Insider Ownership
ATEK Athena Technology Acquisition	88.40%
CRTX Cortexyme	27.90%
HSTM HealthStream	20.60%
OMCL Omnicell	2.52%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATEK Athena Technology Acquisition	2,021	10.15 million	1.18 million	Optionable
CRTX Cortexyme	55	30.15 million	21.74 million	Not Optionable
HSTM HealthStream	1,093	29.64 million	23.54 million	Optionable
OMCL Omnicell	3,670	45.93 million	44.78 million	Optionable

ATEK, CRTX, OMCL, and HSTM Headlines

Recent News About These Companies

Redmond Asset Management LLC Has $4.93 Million Stake in Omnicell, Inc. (NASDAQ:OMCL)

August 17 at 7:22 AM | marketbeat.com

Liontrust Investment Partners LLP Raises Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL)

August 17 at 6:29 AM | marketbeat.com

OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance

August 14, 2025 | finance.yahoo.com

Piper Sandler Reiterates $55.00 Price Target for Omnicell (NASDAQ:OMCL)

August 14, 2025 | americanbankingnews.com

5 Must-Read Analyst Questions From Omnicell’s Q2 Earnings Call

August 13, 2025 | msn.com

Omnicell (NASDAQ:OMCL) Price Target Cut to $55.00 by Analysts at Piper Sandler

August 12, 2025 | marketbeat.com

Connor Clark & Lunn Investment Management Ltd. Buys 24,301 Shares of Omnicell, Inc. (NASDAQ:OMCL)

August 12, 2025 | marketbeat.com

7OMCL : Analyst Expectations For Omnicell ...

August 11, 2025 | benzinga.com

Omnicell (NASDAQ:OMCL) Downgraded to "Buy" Rating by Wall Street Zen

August 10, 2025 | marketbeat.com

Omnicell (NASDAQ:OMCL) Cut to Buy at Wall Street Zen

August 9, 2025 | americanbankingnews.com

1 Small-Cap Stock for Long-Term Investors and 2 We Avoid

August 8, 2025 | finance.yahoo.com

Omnicell management to meet with KeyBanc

August 6, 2025 | msn.com

Omnicell, Inc. (NASDAQ:OMCL) Shares Purchased by XTX Topco Ltd

August 3, 2025 | marketbeat.com

Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript

August 1, 2025 | seekingalpha.com

Omnicell, Inc. 2025 Q2 - Results - Earnings Call Presentation

August 1, 2025 | seekingalpha.com

Omnicell (NASDAQ:OMCL) Shares Gap Up - Here's What Happened

August 1, 2025 | marketbeat.com

Omnicell (NASDAQ:OMCL) Issues Q3 2025 Earnings Guidance

August 1, 2025 | marketbeat.com

Omnicell (NASDAQ:OMCL) Releases FY 2025 Earnings Guidance

August 1, 2025 | marketbeat.com

Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?

August 1, 2025 | zacks.com

Omnicell Shares Climb Over 2% After Second Quarter Results Surpass Expectations

August 1, 2025 | msn.com

Q2 2025 Omnicell Inc Earnings Call Transcript

August 1, 2025 | gurufocus.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATEK, CRTX, OMCL, and HSTM Company Descriptions

Athena Technology Acquisition NYSE:ATEK

Athena Technology Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in Kennesaw, Georgia.

Cortexyme NASDAQ:CRTX

$1.69 +0.01 (+0.60%)

As of 08/15/2025

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

HealthStream NASDAQ:HSTM

$26.68 +0.19 (+0.72%)

Closing price 04:00 PM Eastern

Extended Trading

$26.70 +0.02 (+0.09%)

As of 04:10 PM Eastern

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions. The company provides its solutions to customers across a range of entities within the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through its direct sales teams. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.

Omnicell NASDAQ:OMCL

$31.61 -0.08 (-0.25%)

Closing price 04:00 PM Eastern

Extended Trading

$31.61 0.00 (0.00%)

As of 06:04 PM Eastern

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time